Aptar Digital Health partners with Chiesi Group to bring to market asthma, chronic obstructive pulmonary disease management platform with an initial focus on Europe; in Europe an estimated 6% of people have asthma and 60 million people have COPD

Sample article from our Health Care Sector

October 18, 2022 (press release) –

Aptar Digital Health, part of Aptar Pharma, a global leader in drug delivery and active material science solutions and services, today announced a strategic partnership with the Chiesi Group, the international research-focused biopharmaceutical and healthcare group, to bring to market a disease management platform for asthma and chronic obstructive pulmonary disease (COPD). Aptar Digital Health is a division of Aptar Pharma, part of Aptar (NYSE:ATR).

The partnership will leverage Aptar’s recently announced Disease Management Platform that is designed to empower patients to better understand and take control of their disease, provide healthcare professionals with data-driven insights to better manage their patients and build evidence for emerging reimbursement arrangements in the field of digital health for asthma and COPD. The platform offers a comprehensive set of services and solutions aimed at bringing together both the pharmacological and behavioral aspects of managing respiratory diseases, such as  adherence monitoring, lung function assessment, reporting symptoms, identifying disease triggers and communication with care teams and health coaches. The partnership initially focuses on Europe, with potential future expansions to other geographies.

Respiratory illnesses such as asthma and COPD represent an enormous burden on healthcare systems in Europe. It is estimated that 6% of the current European population is living with asthma, and over 60 million people aged between 30 and 79 years old are thought to be suffering from COPD. The greatest economic burden of respiratory diseases on health services in Europe is due to the chronic problems of COPD and asthma, which currently stands at about €40 billion.

“Aptar Digital Health, with its technology and pharma expertise, is uniquely positioned to offer such a complete solution – from software to connected devices to patient monitoring and data analysis,” said Gael Touya, President of Aptar Pharma. “We are delighted to partner with Chiesi and excited to be able to actively contribute to expanding patient access to holistic, end-to-end services that will durably enhance their respiratory disease management.”

“This collaboration reflects our commitment to providing best-in-class level of care for people living with COPD and asthma, going beyond treatments alone and focusing on the patient experience,” commented Alessandro Chiesi, Chief Commercial Officer of the Chiesi Group. “We are looking forward to leveraging Aptar Digital Health’s deep expertise in disease management, with the goal to improve the quality of life of patients afflicted with respiratory diseases and procure tools that contribute to the sustainability of healthcare services for chronic conditions.”

Added Sai Shankar, President, Aptar Digital Health, “This collaboration leads the way for our recently launched Disease Management Platform offering and reinforces our conviction that end-to-end solutions designed to improve patient care are the future of healthcare.”

Download full Press Release.

 

Reference Sources:

https://ec.europa.eu/eurostat/web/products-eurostat-news/-/edn-20210924-1

https://www.england.nhs.uk/ourwork/clinical-policy/respiratory-disease/

https://www.erswhitebook.org/chapters/the-economic-burden-of-lung-disease/

The cost of respiratory disease – ERS (erswhitebook.org)

 

 

 

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Chelsey Quick
Chelsey Quick
- VP Client Success -

We offer built-to-order health care sector coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.